Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Chondrosarcoma × drozitumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Chondrosarcoma 1

Interventions

venetoclax 1 itacitinib 1 drozitumab 1 birinapant 1 baricitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Leucovorin 1 Irinotecan 1 Ifosfamide 1 INCB039110 1 IFL protocol 1 Gemcitabine 1 Fluorouracil 1 Docetaxel 1 Cyproheptadine 1 Cyclophosphamide 1 Cryosurgery 1 Bevacizumab 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00543712 2022-12-13

A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Genentech, Inc.

Phase 2 Terminated

Chondrosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡